Lesinurad, a Novel Uricosuric Drug for Allopurinol-Refractory Gout Patients

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 2

Abstract

ABSTRACT Gout is the most common type of arthritis in developed countries that is often inadequately managed. Evidence regarding role of hyperuricaemia in poor outcomes in gout patients (e.g., disability, recurrent hospital admissions) with/without other chronic cardiometabolic comorbidities prompts the search of newer and more effective drugs. Current management of gout is limited to NSAIDS and intra-articular corticosteroids in acute gout and Allopurinol or Febuxostat with or without probenecid in chronic gout. Other drugs used as add-on therapy in refractory cases of gout who fail on monotherapy include benzbromarone and pegloticase but with limited role. Though these drugs have been available for several years, significant proportion of compliant patients fail to achieve consistent control of uric acid levels resulting in acute gout flares. Recent advances in the role of urate transporters in proximal tubules of kidney have resulted in the development of new generation uricosuric drugs including lesinurad. It is recently approved by US Food and Drug Administration (US FDA) and European Medicines Agency (EMA) in patients with uncontrolled gout along with Allopurinol or Febuxostat. Hopefully, it will contribute to fulfill the unmet goals in management of gout. This review aims at exploring the current therapeutic strategies for the management of chronic gout patients as well as their limitations and the role of Lesinurad in patients who have failed on monotherapy. The published studies and poster presentations were identified by conducting a literature search from electronic database from 1980 till January 2017, using various medical subject headings and terminologies. These studies were screened and publications considered relevant to the topic were included in the study.

Authors and Affiliations

Yashika Garg, Vishant Gawri, Rajeshwari Gore, Radhe Shyam Garg, Arun Kumar

Keywords

Related Articles

Variations of Adipokines and Insulin Resistance in Primary Hypothyroidism

Introduction: Hypothyroidism is a common concern in endocrinology practice, which plays a significant role in metabolic and development processes. Obesity, hyperlipidaemia and hypertension may complicate hypothyroidism....

Colour Doppler Evaluation of Extracranial Carotid Artery in Patients Presenting with Acute Ischemic Stroke and Correlation with Various Risk Factors

Introduction: Stroke is defined as an abrupt onset of neurologic deficit due to vascular cause. It is one of the leading causes of mortality and morbidity all over the world making early diagnosis and treatment inevitabl...

Evaluating the Marginal Integrity of Bulk Fill Fibre Reinforced Composites in Bio-mimetically Restored Tooth

Introduction: Over the past years, composites in aesthetic dentistry are showing a considerable progress, but mechanical strength and polymerization shrinkage are the two main drawbacks, which limit their use in high str...

Subarachnoid Haemorrhage Following Spinal Anaesthesia in Pregnant Women: A Rare Occurrence

With the increasing trend of caesarean delivery, spinal anaesthesia is the most common anaesthetic procedure performed today. The most common complication following this procedure is post spinal headache. However, more d...

Correlation of Forced Expiratory Time with Anthropometric and Spirometric Indices

ABSTRACT Introduction: Forced Expiratory Time (FET) is the duration of forceful expiration during a Forced Vital Capacity (FVC) manoeuver of spirometry test. Joint recommendation of the American Thoracic Society (ATS) an...

Download PDF file
  • EP ID EP509845
  • DOI 10.7860/JCDR/2018/27997.11149
  • Views 62
  • Downloads 0

How To Cite

Yashika Garg, Vishant Gawri, Rajeshwari Gore, Radhe Shyam Garg, Arun Kumar (2018). Lesinurad, a Novel Uricosuric Drug for Allopurinol-Refractory Gout Patients. Journal of Clinical and Diagnostic Research, 12(2), 1-5. https://europub.co.uk./articles/-A-509845